OncoMatch

OncoMatch/Clinical Trials/NCT04559685

Study of Sonodynamic Therapy in Participants with Recurrent High-Grade Glioma

Is NCT04559685 recruiting? Yes, currently enrolling (May 2026). This Early Phase 1 trial studies multiple treatments including SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS) and MR-Guided Focused Ultrasound device (MRgFUS) for high grade glioma.

Early Phase 1RecruitingNader SanaiNCT04559685Data as of May 2026

Treatment: SONALA-001(ALA) and MR-Guided Focused Ultrasound device (MRgFUS) · MR-Guided Focused Ultrasound device (MRgFUS)A Phase 0 single center, first in human, open-label study of ascending energy doses of sonodynamic therapy (SDT) utilizing the MRgFUS combined with intravenous ALA to assess safety and efficacy in up to 45 participants with recurrent HGG. Eligible participants who are scheduled for resection will be administered intravenous (IV) aminolevulinic acid HCl (ALA) approximately six to seven (6-7) hours prior to receiving sonodynamic therapy (SDT).

Check if I qualify

Extracted eligibility criteria

Cancer type

Glioblastoma

Biomarker criteria

Required: MGMT unmethylated

Disease stage

Required: Stage III, IV

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

Min 1 prior line

Must have received: standard therapy

participants who have progressed on or following standard therapy as determined by the investigator

Cannot have received: investigational drug

Treatment with another investigational drug within 30 days prior to enrollment or within 5 half-lives of the investigational product, whichever is longer.

Lab requirements

Blood counts

absolute neutrophil count ≥1,000/mcL; Platelets ≥100,000/mcL; hemoglobin ≥8.0 g/dL

Kidney function

Serum creatinine ≤1.5 X ULN

Liver function

total bilirubin ≤1.5 X ULN (≤2.0 X ULN for Gilbert's syndrome); AST(SGOT) ≤3 X ULN; ALT(SGPT) ≤3 X ULN; GGT ≤3 X ULN

Adequate bone marrow and organ function as defined by the following laboratory values...

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • St. Joseph's Hospital and Medical Center · Phoenix, Arizona

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify